Simparica for dogs: indications and safety

Simparica includes medicines intended for dogs. All information must refer to the exact presentation and its summary of product characteristics.

Correct species and product

The article does not extend Simparica to cats and does not mix different presentations. The active substance, weight range and target parasites are checked in the official document.

Pharmacokinetic data that are unnecessary for the owner’s decision are omitted to avoid errors and false precision.

Authorised indications

Protection is described only for the parasites and duration stated in the summary of product characteristics for the pack. Superlatives and commercial comparisons are not used.

The choice takes individual risk and any other treatments into account.

Precautions

Age, weight and clinical history must comply with the package leaflet. Any unexpected reaction should be reported to the veterinarian before further administration.

Sources and document updates

This information is general and does not replace diagnosis, prescription or instructions from a veterinarian. For a medicine, the summary of product characteristics or package leaflet for the specific presentation is authoritative.

• European Medicines Agency — Simparica - EPAR (accessed 24/07/2026)
• Union Product Database — Veterinary medicines authorised in the European Union (accessed 24/07/2026)

Editorial transparency: sources are provided to allow the documents to be checked. Professional review is only declared after genuine approval by a qualified, identifiable person.